Other resolutions: 330 220 pixels | 960 640 pixels | 1,280 853 pixels | 3,840 2,560 pixels
In essence, Bayesian outputs do not offer additional conclusions
Triagonists in preclinical/clinical research have also demonstrated some superior beneficial effects compared to dual agonists, which include reduction of body weight, enhancement of glycaemic control and the reversal of nonalcoholic steatohepatitis (NASH) (Capozzi et al., 2018)
In contrast, discontinuation by dosing frequency was comparable for weekly and daily doses at 12 months and more frequent among weekly users at 24 months
The 9mg dose represents a strong option for researchers who want near-maximum results with a more tolerable side effect profile
People who can afford the drug will keep taking it